Jeff Smith's Insider Trades & SAST Disclosures
Jeff Smith's most recent trade in C & F Financial Corp was a trade of 425 Common Stock done . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeff Smith.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C & F Financial Corp | Jeffery O. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 425 | 2,670 (0%) | 0% | 0 | Common Stock | |
| Kenvue Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 307 | 1,997 | - | - | Deferred Share Units | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 416 | 6,596 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 257 | 6,180 | - | - | Common Share Equivalent | |
| Kenvue Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 1,690 | 1,690 | - | - | Deferred Share Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 519 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 519 | 87,959 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 4.91 per share. | 03 Mar 2025 | 154 | 87,805 (0%) | 0% | 4.9 | 756 | Common Stock |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Purchase of securities on an exchange or from another person at price $ 18.96 per share. | 28 Jan 2025 | 650 | 33,609 (0%) | 0% | 19.0 | 12,324 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 29,168 | 97,727 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 16,219 | 32,438 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 10,449 | 20,894 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 4.79 per share. | 20 Jan 2025 | 10,287 | 87,440 (0%) | 0% | 4.8 | 49,275 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 2,500 | 2,500 | - | - | Restricted Stock Units | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 53,000 | 53,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2025 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2025 | 20,000 | 40,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 06 Jan 2025 | 11,110 | 8,890 (0%) | 0% | 14.9 | 165,807 | Common Stock |
| Midland States Bancorp Inc | Smith C. Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 315 | 5,923 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 183 | 5,607 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 343 | 5,424 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 214 | 5,080 | - | - | Common Share Equivalent | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 9 | 18 | - | - | Dividend Equivalent Rights (RSUs) | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 7 | 27 | - | - | Dividend Equivalent Rights (DSUs) | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 48,657 | 48,657 | - | - | Restricted Stock Units | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 164 | 2,203 | - | - | Deferred Share Units | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,326 | 4,866 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 165 | 2,539 | - | - | Common Share Equivalent | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 9 | 9 | - | - | Dividend Equivalent Rights (RSUs) | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 7 | 20 | - | - | Dividend Equivalent Rights (DSUs) | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 163 | 68,609 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 163 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 11.80 per share. | 07 Jun 2024 | 50 | 68,559 (0%) | 0% | 11.8 | 590 | Common Stock |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 2,630 | 2,630 | - | - | Restricted Share Units | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 443 | 2,039 | - | - | Deferred Share Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 08 May 2024 | 833 | 68,446 (0%) | 0% | 12 | 9,996 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 31,343 | 31,343 | - | - | Restricted Stock Units | |
| C & F Financial Corp | Jeffery O. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 600 | 2,245 (0%) | 0% | 0 | Common Stock | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 239 | 2,374 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 148 | 2,135 | - | - | Common Share Equivalent | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 451 | 1,596 | - | - | Deferred Share Units | |
| Ritchie Bros Auctioneers Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 7 | 13 | - | - | Dividend Equivalent Rights | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 12.42 per share. | 29 Feb 2024 | 1,006 | 67,248 (0%) | 0% | 12.4 | 12,495 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 519 | 519 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 519 | 67,767 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 10.32 per share. | 29 Feb 2024 | 154 | 67,613 (0%) | 0% | 10.3 | 1,589 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 75,015 | 2,015,269 (3%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 75,015 | 149,985 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Smith Jeff | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 20 Jan 2024 | 28,000 | 1,987,269 (3%) | 0% | 0.4 | 10,360 | Common Stock |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Jeffrey T.L. Smith | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 60,000 | 60,000 | - | - | Restricted Stock Unit | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 152 | 1,906 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Smith Jeffrey C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 80 | 1,986 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 150 | 1,644 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 108 | 1,753 | - | - | Common Share Equivalent | |
| Cambridge Bancorp | Jeffrey F. Smith | EVP/Head of Wealth Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 8,811 | 8,811 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,872 | 4,872 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,872 | 1,935,079 (3%) | 0% | - | Common Stock | |
| C & F Financial Corp | Jeffery O. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 500 | 1,645 (0%) | 0% | 0 | Common Stock | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 105 | 1,232 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 103 | 1,127 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Purchase of securities on an exchange or from another person at price $ 23.13 per share. | 13 Mar 2023 | 330 | 32,106 (0%) | 0% | 23.1 | 7,633 | Common Stock |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 937,564 | 312,521 (0%) | 2% | 82.5 | 77,367,781 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 429,630 | 0 (0%) | 1% | 82.5 | 35,453,068 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 309,080 | 103,027 (0%) | 0% | 82.5 | 25,505,282 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 175,544 | 58,514 (0%) | 0% | 82.5 | 14,485,891 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 132,253 | 44,085 (0%) | 0% | 82.5 | 10,913,518 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 99,259 | 33,086 (0%) | 0% | 82.5 | 8,190,853 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | See Footnote 1 | Sale or transfer of securities back to the company at price $ 82.52 per share. | 01 Mar 2023 | 93,598 | 31,199 (0%) | 0% | 82.5 | 7,723,707 | Common Stock, par value $0.01 per share |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 15,576 | 31,144 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 15,576 | 1,930,207 (3%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 28 Feb 2023 | 12,157 | 1,914,631 (3%) | 0% | 0.9 | 11,549 | Common Stock |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 94.88 per share. | 17 Feb 2023 | 51 | 17,138 (0%) | 0% | 94.9 | 4,839 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 95.55 per share. | 17 Feb 2023 | 22 | 17,087 (0%) | 0% | 95.5 | 2,102 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 89.80 per share. | 31 Jan 2023 | 348 | 17,065 (0%) | 0% | 89.8 | 31,250 | Common Stock, par value $0.01 per share |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 225,000 | 225,000 | - | - | Restricted Stock Units | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 92 | 939 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 83 | 1,023 | - | - | Common Share Equivalent | |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 83.33 per share. | 25 Nov 2022 | 58 | 16,717 (0%) | 0% | 83.3 | 4,833 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 84.61 per share. | 25 Nov 2022 | 23 | 16,659 (0%) | 0% | 84.6 | 1,946 | Common Stock, par value $0.01 per share |
| World Kinect Corp | Jeffrey P. Smith | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.60 per share. | 10 Nov 2022 | 7,339 | 101,866 (0%) | 0% | 27.6 | 202,556 | Common Stock |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 94 | 847 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 90 | 753 | - | - | Common Share Equivalent | |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 82.03 per share. | 26 Aug 2022 | 59 | 16,635 (0%) | 0% | 82.0 | 4,840 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 84.17 per share. | 26 Aug 2022 | 23 | 16,576 (0%) | 0% | 84.2 | 1,936 | Common Stock, par value $0.01 per share |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 1,664 | 8,107 | - | - | Restricted Stock Unit | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 92 | 662 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 79 | 570 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 2,009 | 10,116 | - | - | Restricted Stock Unit | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Purchase of securities on an exchange or from another person at price $ 24.80 per share. | 10 Jun 2022 | 853 | 32,959 (0%) | 0% | 24.8 | 21,153 | Common Stock |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 149 | 1,382 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 111 | 1,493 | - | - | Common Share Equivalent | |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 88.00 per share. | 27 May 2022 | 45 | 16,553 (0%) | 0% | 88 | 3,960 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 89.28 per share. | 27 May 2022 | 18 | 16,508 (0%) | 0% | 89.3 | 1,607 | Common Stock, par value $0.01 per share |
| Papa John`s International,... | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 2,395 | 16,490 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 66 | 442 | - | - | Common Share Equivalent | |
| Midland States Bancorp Inc | Jeffrey C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 48 | 490 | - | - | Common Share Equivalent | |
| World Kinect Corp | Jeffrey P. Smith | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 17,337 | 109,205 (0%) | 0% | 0 | Common Stock | |
| World Kinect Corp | Jeffrey P. Smith | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 11,909 | 91,868 (0%) | 0% | 0 | Common Stock | |
| World Kinect Corp | Jeffrey P. Smith | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.38 per share. | 15 Mar 2022 | 4,167 | 83,473 (0%) | 0% | 25.4 | 105,758 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges